Virtue Capital Management, LLC Abb Vie Inc. Transaction History

Virtue Capital Management, LLC

$477 Million
Q3 2024

A detailed history of Virtue Capital Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Virtue Capital Management, LLC holds 4,756 shares of ABBV stock, worth $856,080. This represents 0.2% of its overall portfolio holdings.

Number of Shares

4,756

Previous 5,071 6.21%

Holding current value

$856,080

Previous $869,000 8.06%

% of portfolio

0.2%

Previous 0.15%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 18, 2024	SELL	$163.84 - $199.33 $51,609 - $62,788	-315 Reduced 6.21%	4,756 $939,000
Q2 2024 Aug 13, 2024	BUY	$154.79 - $180.76 $123,522 - $144,246	798 Added 18.68%	5,071 $869,000
Q1 2024 May 15, 2024	SELL	$159.82 - $182.1 $46,187 - $52,626	-289 Reduced 6.33%	4,273 $778,000
Q4 2023 Feb 15, 2024	SELL	$137.6 - $154.97 $112,006 - $126,145	-814 Reduced 15.14%	4,562 $706,000
Q2 2023 Jul 18, 2023	SELL	$132.51 - $164.9 $4,372 - $5,441	-33 Reduced 0.61%	5,376 $724,000
Q1 2023 May 11, 2023	SELL	$144.61 - $166.54 $54,807 - $63,118	-379 Reduced 6.55%	5,409 $862,000
Q4 2022 Feb 10, 2023	BUY	$138.31 - $165.87 $800,538 - $960,055	5,788 New	5,788 $935,000
Q2 2022 Aug 10, 2022	SELL	$137.62 - $174.96 $1.62 Million - $2.06 Million	-11,777 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$131.98 - $163.75 $884,002 - $1.1 Million	6,698 Added 131.88%	11,777 $1.91 Million
Q4 2021 Jan 24, 2022	BUY	$107.43 - $135.93 $131,279 - $166,106	1,222 Added 31.68%	5,079 $688,000
Q3 2021 Nov 12, 2021	SELL	$106.4 - $120.78 $77,991 - $88,531	-733 Reduced 15.97%	3,857 $416,000
Q2 2021 Jul 15, 2021	BUY	$105.21 - $117.21 $21,147 - $23,559	201 Added 4.58%	4,590 $517,000
Q1 2021 May 13, 2021	SELL	$102.3 - $112.62 $82,044 - $90,321	-802 Reduced 15.45%	4,389 $475,000
Q4 2020 Feb 16, 2021	SELL	$80.49 - $108.67 $190,519 - $257,221	-2,367 Reduced 31.32%	5,191 $556,000
Q3 2020 Nov 16, 2020	SELL	$85.91 - $100.83 $295,959 - $347,359	-3,445 Reduced 31.31%	7,558 $662,000
Q2 2020 Aug 10, 2020	BUY	$73.37 - $98.18 $807,290 - $1.08 Million	11,003 New	11,003 $1.08 Million
Q1 2020 May 13, 2020	SELL	$64.5 - $97.79 $398,223 - $603,755	-6,174 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$72.13 - $90.25 $237,307 - $296,922	-3,290 Reduced 34.76%	6,174 $547,000
Q3 2019 Nov 12, 2019	SELL	$62.98 - $75.72 $38,039 - $45,734	-604 Reduced 6.0%	9,464 $717,000
Q2 2019 Nov 12, 2019	BUY	$65.7 - $83.98 $661,467 - $845,510	10,068 New	10,068 $732,000
Q4 2018 Feb 13, 2019	SELL	$77.85 - $96.01 $558,651 - $688,967	-7,176 Closed	0 $0
Q3 2018 Feb 13, 2019	BUY	$88.91 - $98.84 $190,445 - $211,715	2,142 Added 42.55%	7,176 $679,000
Q2 2018 Aug 14, 2018	BUY	$89.78 - $106.23 $176,597 - $208,954	1,967 Added 64.13%	5,034 $466,000
Q1 2018 May 15, 2018	BUY	$92.01 - $123.21 $150,160 - $201,078	1,632 Added 113.73%	3,067 $286,000
Q4 2017 Feb 14, 2018	BUY	$89.56 - $98.21 $128,518 - $140,931	1,435	1,435 $139,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtue Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtue Capital Management, LLC with notifications on news.

Account

Virtue Capital Management, LLC Abb Vie Inc. Transaction History